ReviewOphthalmology and therapy2026
An Evidence-Based Pathway from Functional Classification to Intraocular Lens Specialization: A Case Example Applying the PECO Framework.
Review in Ophthalmology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Simultaneous vision intraocular lenses (SVIOLs) aim to extend postoperative depth of field (DOFi) and reduce spectacle dependence after cataract or refractive lens exchange surgery. To support evidence-based selection among the growing number of SVIOL models, the predict-explore-confirm-optimize (PECO) framework is proposed as a structured SVIOL evidence development framework to guide systematic evidence generation and clinical decision-making. PECO is implemented as a sequential pathway for evidence generation, in which optical bench testing is performed first (Predict), early clinical experience is subsequently accumulated (Explore), outcomes and safety are then confirmed in large peer-reviewed clinical studies (Confirm), and patient- and procedure-specific factors are finally addressed through targeted research (Optimize). This review applies the PECO framework to a case example: the Liberty trifocal SVIOL, which has been clinically validated as a Full-DOFi Smooth SVIOL. Beyond standard safety and efficacy outcomes, evidence in the Optimization stage addresses patient expectations, dysphotopsia risk, contrast sensitivity, biometric accuracy, corneal aberrations, pupil size, centration, and posterior capsular opacification. The Liberty example illustrates how evidence extending beyond functional classification can refine patient selection, surgical planning, and counseling. Overall, the PECO framework emphasizes that optimal SVIOL outcomes depend not only on confirmed functional performance, but also on individualized, evidence-informed specialization tailored to patient characteristics and clinical context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.